Abstract
Hepatitis B vaccination is not widespread amongst staff in accident and emergency departments in the United Kingdom. The results of a survey of departments training senior registrars reveal that unfounded fears concerning the safety of the vaccine are responsible for the low uptake. The need for vaccination, cost, medicolegal aspects and future developments are discussed.
Full text
PDF









Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alexander G., Williams R. Antiviral treatment in chronic infection with hepatitis B virus. Br Med J (Clin Res Ed) 1986 Oct 11;293(6552):956–956. doi: 10.1136/bmj.293.6552.956-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Callender M. E., White Y. S., Williams R. Hepatitis B virus infection in medical and health care personnel. Br Med J (Clin Res Ed) 1982 Jan 30;284(6312):324–326. doi: 10.1136/bmj.284.6312.324. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gatley M. S. Time for action on hepatitis B immunisation. Br Med J (Clin Res Ed) 1987 Feb 21;294(6570):509–509. doi: 10.1136/bmj.294.6570.509. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Geddes A. M. Hepatitis B and HTLV3 infection in injured patients. Injury. 1986 Sep;17(5):293–294. doi: 10.1016/0020-1383(86)90147-6. [DOI] [PubMed] [Google Scholar]
- Golden J. A. No increased incidence of AIDS in recipients of hepatitis B vaccine. N Engl J Med. 1983 May 12;308(19):1163–1164. doi: 10.1056/NEJM198305123081914. [DOI] [PubMed] [Google Scholar]
- Mulley A. G., Silverstein M. D., Dienstag J. L. Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis. N Engl J Med. 1982 Sep 9;307(11):644–652. doi: 10.1056/NEJM198209093071103. [DOI] [PubMed] [Google Scholar]
- Polakoff S. Acute viral hepatitis B: laboratory reports 1980-4. Br Med J (Clin Res Ed) 1986 Jul 5;293(6538):37–38. doi: 10.1136/bmj.293.6538.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Polakoff S. Decrease in acute hepatitis B incidence in England and Wales in 1985-86. Lancet. 1987 Feb 14;1(8529):380–380. doi: 10.1016/s0140-6736(87)91747-8. [DOI] [PubMed] [Google Scholar]
- Prevalence of HBsAg in UK population. Br Med J (Clin Res Ed) 1987 Jan 3;294(6563):57–57. doi: 10.1136/bmj.294.6563.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Triger D. R. Hepatitis B immunization: experience in a provincial centre. Health Trends. 1984 May;16(2):41–43. [PubMed] [Google Scholar]
- Vandervelde E. M., Mortimer P. P. New hepatitis B vaccines. Br Med J (Clin Res Ed) 1985 Mar 9;290(6470):787–787. doi: 10.1136/bmj.290.6470.787-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zuckerman A. J. Time for action on hepatitis B immunization. Br Med J (Clin Res Ed) 1987 Mar 21;294(6574):771–771. doi: 10.1136/bmj.294.6574.771. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zuckerman A. J. Who should be immunised against hepatitis B? Br Med J (Clin Res Ed) 1984 Nov 10;289(6454):1243–1244. doi: 10.1136/bmj.289.6454.1243. [DOI] [PMC free article] [PubMed] [Google Scholar]